Pipeline

Immuno-Oncology PreClinical Clinical Rights
Fate-NK100 – AML

Worldwide
Fate-NK100 – Solid Tumor mAb Combo

Worldwide
Fate-NK100 – Ovarian

Worldwide
Engineered hnCD16 iNK

Worldwide
Engineered CAR iT Cell

Worldwide
Ex Vivo T-Cell Modulation Collaboration

Milestone / Royalties
IMMUNO-REGULATION
ProTmune™ – Graft-versus-Host Disease

Worldwide
ToleraCyte™ – Autoimmune Disorders

Worldwide
Engineered iReg Cell

Worldwide
Immuno-Oncology Phase Rights
Fate-NK100 – AML Clinical Worldwide
Fate-NK100 – Solid Tumor mAb Combo Clinical Worldwide
Fate-NK100 – Ovarian Preclinical Worldwide
Engineered hnCD16 iNK Preclinical Worldwide
Engineered CAR iT Cell Preclinical Worldwide
Ex Vivo T-Cell Modulation Collaboration Preclinical Milestone / Royalties
IMMUNO-REGULATION
ProTmune™ – Graft-versus-Host Disease Clinical Worldwide
ToleraCyte™ – Autoimmune Disorders Preclinical Worldwide
Engineered iReg Cell Preclinical Worldwide